These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 6975300)
1. Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. Rabin H; Hopkins RF; Ruscetti FW; Neubauer RH; Brown RL; Kawakami TG J Immunol; 1981 Nov; 127(5):1852-6. PubMed ID: 6975300 [TBL] [Abstract][Full Text] [Related]
2. A biochemical variant of human T cell growth factor produced by a cutaneous T cell lymphoma cell line. Gootenberg JE; Ruscetti FW; Gallo RC J Immunol; 1982 Oct; 129(4):1499-505. PubMed ID: 6980938 [TBL] [Abstract][Full Text] [Related]
3. The effect of T cell growth factor on the cell cycle of primate T cells. Brown RL; Griffith RL; Neubauer RH; Rabin H J Immunol; 1982 Nov; 129(5):1849-53. PubMed ID: 6981667 [TBL] [Abstract][Full Text] [Related]
4. Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression. Pawelec G; Rehbein A; Müller C; Sonneborn HH; Wernet P Immunology; 1981 Apr; 42(4):529-40. PubMed ID: 6453828 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms controlling TCGF production by cloned sublines of EL-4 azgr in response to stimulation by anti-Thy-1 antibody. Shimizu S; Smith RT; Norcross MA; Maino VC J Immunol; 1982 Jan; 128(1):296-301. PubMed ID: 6119343 [TBL] [Abstract][Full Text] [Related]
6. Human helper T cell factor(s) (ThF). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell-replacing factor- (TRF) like factor(s). Teranishi T; Hirano T; Arima N; Onoue K J Immunol; 1982 Apr; 128(4):1903-8. PubMed ID: 6801125 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 production in continuous culture. Krömer E; Lutz D; Scheirer W Dev Biol Stand; 1983; 55():129-30. PubMed ID: 6610585 [TBL] [Abstract][Full Text] [Related]
8. Human T-cell growth factor: parameters for production. Ruscetti FW; Mier JW; Gallo RC J Supramol Struct; 1980; 13(2):229-41. PubMed ID: 6972470 [TBL] [Abstract][Full Text] [Related]
9. A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor. Schrader JW; Clark-Lewis I J Immunol; 1982 Jul; 129(1):30-5. PubMed ID: 6979567 [TBL] [Abstract][Full Text] [Related]
10. Growth of human normal and leukemic T cells: T-cell growth factor (TCGF) and the isolation of a new class of RNA tumor viruses (HTLV). Gallo RC Blood Cells; 1981; 7(2):313-29. PubMed ID: 6975142 [TBL] [Abstract][Full Text] [Related]
11. Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF. Yung YP; Eger R; Tertian G; Moore MA J Immunol; 1981 Aug; 127(2):794-9. PubMed ID: 6788848 [TBL] [Abstract][Full Text] [Related]
12. The purification and properties of human T cell growth factor. Mier JW; Gallo RC J Immunol; 1982 Mar; 128(3):1122-7. PubMed ID: 6976987 [TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. I. Separation of T cell growth factor and T cell replacing factor from granulocyte-macrophage colony-stimulating factor. Clark-Lewis I; Schrader JW J Immunol; 1982 Jan; 128(1):168-74. PubMed ID: 6976369 [TBL] [Abstract][Full Text] [Related]
14. Identification of phorbol ester receptors in T-cell growth factor-producing and -nonproducing EL4 mouse thymoma cells. Sando JJ; Hilfiker ML; Piacentini MJ; Laufer TM Cancer Res; 1982 May; 42(5):1676-80. PubMed ID: 6978177 [TBL] [Abstract][Full Text] [Related]
15. Human spleen as a source of T cell growth factor. Moretta A; Colombatti M; Chapuis B Clin Exp Immunol; 1981 May; 44(2):262-9. PubMed ID: 6975673 [TBL] [Abstract][Full Text] [Related]
16. Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer. Rosenberg SA; Eberlein TJ; Grimm EA; Lotze MT; Mazumder A; Rosenstein M Surgery; 1982 Aug; 92(2):328-36. PubMed ID: 6980492 [TBL] [Abstract][Full Text] [Related]
17. A rapid, large scale purification procedure for gibbon interleukin 2. Henderson LE; Hewetson JF; Hopkins RF; Sowder RC; Neubauer RH; Rabin H J Immunol; 1983 Aug; 131(2):810-5. PubMed ID: 6602847 [TBL] [Abstract][Full Text] [Related]
18. Alloreactive cloned T cell lines. V. Differential kinetics of IL 2, CSF, and BCSF release by a cloned T amplifier cell and its variant. Ely JM; Prystowsky MB; Eisenberg L; Quintans J; Goldwasser E; Glasebrook AL; Fitch FW J Immunol; 1981 Dec; 127(6):2345-9. PubMed ID: 6975317 [TBL] [Abstract][Full Text] [Related]
19. Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. II. Evidence for glycosylation of T cell growth factor, T cell replacing factor, and granulocyte-macrophage colony-stimulating factor. Clark-Lewis I; Schrader JW J Immunol; 1982 Jan; 128(1):175-80. PubMed ID: 6976370 [TBL] [Abstract][Full Text] [Related]
20. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma. Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]